Our CRDs EvidenceTM practice documents the clinical, economic, and humanistic value of innovative drugs and devices before and after product approval and launch. With uncommon technical expertise and decades of practical, strategic perspective, our experts work to objectively and credibly establish evidence of value in actual practice (real-world) settings, using operational techniques that increasingly embrace advanced technology.
Who do we support? Our real-world evidence services are tailored to life-sciences industry professionals in Medical Affairs, Health Economics, Real-World Evidence, Market Access, Late-Stage Clinical Research, Epidemiology, Patient Advocacy, Medical Communications, and Product Management. We deliver an uncommon combination of global experience and operational expertise from planning through execution and publication, including:
- Evidence Needs Assessments
- Burden of Illness Studies
- Cost of Illness Analyses
- Patient Registries
- Patient-centric Outcomes Research
- Post-approval Safety Surveillance
- Cost-effectiveness Studies
- Product Economic Dossiers
- Literature Reviews
- Economic Modeling
- Non-interventional Studies
- PRO (Patient-reported Outcomes) Research